MV has mentioned "engagement with regulators" as key priority for the company, time and again in his presentations. I would love to know what this means. Whether it's as per last week's announcement for FDA fast track approval. Or is this to seek expedited approval on the back of AIPAC phase 2b results?
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep Investor Update
Ann: Immutep Investor Update, page-16
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 133736 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.355 |
2 | 9500 | 0.350 |
7 | 319326 | 0.345 |
13 | 275346 | 0.340 |
3 | 64311 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 133736 | 5 |
0.365 | 158076 | 7 |
0.370 | 228871 | 10 |
0.375 | 209760 | 5 |
0.380 | 220968 | 12 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |